Obinutuzumab in Combination With GDP Chemotherapy in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma
Clinical trial NCT02750670 · COMPLETED
Trial details
- NCT number
- NCT02750670
- Sponsor
- University Health Network, Toronto
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-15
- Primary completion
- 2020-09-09
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.